Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Vaccines |
Free Subscription
2 Clin Infect Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
Vaccine-Preventable Disease Outbreaks among Healthcare Workers: A Scoping Review.
Clin Infect Dis. 2024 Apr 17:ciae209. doi: 10.1093.
PubMed
Abstract available
Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute
Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019
Messenger RNA Vaccine Recipients.
Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
PubMed
Correction to: Interim Report of the Reactogenicity and Immunogenicity of Severe
Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines.
J Infect Dis. 2024 Apr 18:jiae186. doi: 10.1093.
PubMed
Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing
schedule, vaccine sentiment, targeting strategy, and duration of protection.
J Infect Dis. 2024 Apr 17:jiae123. doi: 10.1093.
PubMed
Abstract available
What if We Had a Vaccine that Prevents Neisseria gonorrhoeae.
J Infect Dis. 2024 Apr 17:jiae160. doi: 10.1093.
PubMed
Environmental Surveillance for Salmonella Typhi and its Association With Typhoid
Fever Incidence in India and Malawi.
J Infect Dis. 2024;229:979-987.
PubMed
Abstract available
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional
Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High
Anti-Hepatitis B Surface Antigen Titers.
J Infect Dis. 2024;229:1077-1087.
PubMed
Abstract available
Modeling Poliovirus Transmission and Responses in New York State.
J Infect Dis. 2024;229:1097-1106.
PubMed
Abstract available
Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis
virus envelope protein is(are) important to elicit protective immunity.
J Virol. 2024;98:e0177323.
PubMed
Abstract available
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged >/=10 Years:
Recommendations of the Advisory Committee on Immunization Practices - United
States, 2023.
MMWR Morb Mortal Wkly Rep. 2024;73:345-350.
PubMed
Abstract available
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19
Omicron-Associated Hospitalization in Children and Adolescents - United States,
2021-2023.
MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
PubMed
Abstract available
COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and
COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National
Healthcare Safety Network, United States, October 2023-February 2024.
MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
PubMed
Abstract available
Measles - United States, January 1, 2020-March 28, 2024.
MMWR Morb Mortal Wkly Rep. 2024;73:295-300.
PubMed
Abstract available
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase
2/3 randomized trial.
Nat Med. 2024 Apr 18. doi: 10.1038/s41591-024-02955.
PubMed
Abstract available
Policy Approaches for Increasing Adolescent HPV Vaccination Coverage: A
Systematic Review.
Pediatrics. 2024 Apr 16:e2023064692. doi: 10.1542/peds.2023-064692.
PubMed
Abstract available
Potential impact of annual vaccination with reformulated COVID-19 vaccines:
Lessons from the US COVID-19 scenario modeling hub.
PLoS Med. 2024;21:e1004387.
PubMed
Abstract available
Facilitators and barriers to vaccination uptake in pregnancy: A qualitative
systematic review.
PLoS One. 2024;19:e0298407.
PubMed
Abstract available
Pneumococcal vaccination and primary care presentations for acute respiratory
tract infection and antibiotic prescribing in older adults.
PLoS One. 2024;19:e0299924.
PubMed
Abstract available
Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent
mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein
receptor-binding domains in mice.
PLoS One. 2024;19:e0300524.
PubMed
Abstract available
mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in
mice from influenza A virus challenge.
PLoS One. 2024;19:e0297833.
PubMed
Abstract available
Regional variations in vaccination against COVID-19 in Germany.
PLoS One. 2024;19:e0296976.
PubMed
Abstract available
COVID-19 vaccine hesitancy among adults in Liberia, April-May 2021.
PLoS One. 2024;19:e0297089.
PubMed
Abstract available
Translation and trans-cultural adaptation to the Malay version of the COVID-19
vaccine hesitancy questionnaire among healthcare workers in Malaysia.
PLoS One. 2024;19:e0302237.
PubMed
Abstract available
Higher correlation between neutralizing antibodies and surrogate neutralizing or
binding antibodies in COVID-19 patients than vaccine recipients.
PLoS One. 2024;19:e0298033.
PubMed
Abstract available
Effects of COVID-19 vaccine safety framing on parental reactions.
PLoS One. 2024;19:e0302233.
PubMed
Abstract available
Peak transgene expression after intramuscular immunization of mice with
adenovirus 26-based vector vaccines correlates with transgene-specific adaptive
immune responses.
PLoS One. 2024;19:e0299215.
PubMed
Abstract available
Effectiveness of the online-eLearning program KeepCoool at improving the vaccine
cold chain in general practices.
PLoS One. 2024;19:e0301847.
PubMed
Abstract available
High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
PLoS One. 2024;19:e0277072.
PubMed
Abstract available
Assessing the impact of Australia's mass vaccination campaigns over the Delta and
Omicron outbreaks.
PLoS One. 2024;19:e0299844.
PubMed
Abstract available
Completion of three-dose hepatitis B vaccination cycle and associated factors
among health care workers in the Greater Accra Region of Ghana.
PLoS One. 2024;19:e0298771.
PubMed
Abstract available
Immunogenic profile of a plant-produced nonavalent African horse sickness viral
protein 2 (VP2) vaccine in IFNAR-/- mice.
PLoS One. 2024;19:e0301340.
PubMed
Abstract available
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among
nursing home residents-Georgia, October 2020-July 2022.
PLoS One. 2024;19:e0301367.
PubMed
Abstract available
Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
Proc Natl Acad Sci U S A. 2024;121:e2314357121.
PubMed
Abstract available
Live-attenuated virus vaccine defective in RNAi suppression induces rapid
protection in neonatal and adult mice lacking mature B and T cells.
Proc Natl Acad Sci U S A. 2024;121:e2321170121.
PubMed
Abstract available
Plans to expand African vaccine production face steep hurdles.
Science. 2024;384:254-255.
PubMed
Abstract available
Planting a chemical flag on antigens.
Science. 2024;384:41-42.
PubMed
Abstract available
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored
vaccine against H9N2 low pathogenic avian influenza in chicken.
Vaccine. 2024 Apr 18:S0264-410X(24)00452-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Safety of concomitant administration of 23-valent polysaccharide pneumococcal
vaccine and influenza vaccine among the elderly.
Vaccine. 2024 Apr 18:S0264-410X(24)00400-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines
among a convenience sample in Minnesota.
Vaccine. 2024 Apr 18:S0264-410X(24)00480-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive
registry-based cohort study of over 800,000 individuals.
Vaccine. 2024 Apr 18:S0264-410X(24)00464-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations
after four years of its introduction into the Polish National Immunisation
Programme: Follow-up study.
Vaccine. 2024 Apr 18:S0264-410X(24)00433-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in
inner city Vancouver, Canada: Insights into characteristics and clinical
outcomes.
Vaccine. 2024 Apr 17:S0264-410X(24)00477-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Impact of nutritional status on vaccine-induced immunity in children living in
South Africa: Investigating the B-cell repertoire and metabolic hormones.
Vaccine. 2024 Apr 17:S0264-410X(24)00448-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate
vaccine (PNEUBEVAX 14) administered to 6-8 weeks old healthy Indian Infants: A
single blind, randomized, active-controlled, Phase-III study.
Vaccine. 2024 Apr 17:S0264-410X(24)00362-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Erratum to "Immunogenicity of an adenovirus-vectored bivalent vaccine against
wild type SARS-CoV-2 and Omicron variants in a murine model" [Vaccine 42(6)
(2024) 1292-1299].
Vaccine. 2024 Apr 16:S0264-410X(24)00386-4. doi: 10.1016/j.vaccine.2024.
PubMed
Analysis of causal relations between vaccine hesitancy for COVID-19 vaccines and
ideological orientations in Brazil.
Vaccine. 2024 Apr 16:S0264-410X(24)00436-5. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Overview of U.S. COVID-19 vaccine safety surveillance systems.
Vaccine. 2024 Apr 16:S0264-410X(24)00224-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and
message framing among black and white participants.
Vaccine. 2024 Apr 16:S0264-410X(24)00402-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Understanding the views of adult migrants around catch-up vaccination for missed
routine immunisations to define strategies to improve coverage: A UK in-depth
interview study.
Vaccine. 2024 Apr 16:S0264-410X(24)00406-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Cost-effectiveness of high-dose influenza vaccination in the Netherlands:
Incorporating the impact on both respiratory and cardiovascular hospitalizations.
Vaccine. 2024 Apr 17:S0264-410X(24)00465-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Measles outbreak associated with a preschool setting among partially vaccinated
children in the Tel Aviv District, Israel, October 2023.
Vaccine. 2024 Apr 15:S0264-410X(24)00427-4. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Patient concerns and physician strategies for addressing COVID-19 vaccine
hesitancy.
Vaccine. 2024 Apr 15:S0264-410X(24)00437-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy
and uptake among Chinese adults in Hong Kong.
Vaccine. 2024 Apr 15:S0264-410X(24)00449-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Incidence of pneumococcal disease in children =48 months old in the United
States: 1998-2019.
Vaccine. 2024;42:2758-2769.
PubMed
Abstract available
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector
protects hamsters from SARS-CoV-2 challenge.
Vaccine. 2024 Mar 19:S0264-410X(24)00327-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein
expressed by Escherichia coli and baculovirus-insect cells.
Vaccine. 2024;42:2848-2857.
PubMed
Abstract available
Evaluating the health and economic outcomes of a PCV15 vaccination program for
adults aged 65 years-and-above in Switzerland.
Vaccine. 2024 Apr 11:S0264-410X(24)00431-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
An economic evaluation and incremental analysis of the cost effectiveness of
three universal childhood varicella vaccination strategies for Ireland.
Vaccine. 2024 Apr 11:S0264-410X(24)00441-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in
healthy Japanese participants 1 year of age and older.
Vaccine. 2024 Apr 12:S0264-410X(24)00388-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Super epitope dengue vaccine instigated serotype independent immune protection
in-silico.
Vaccine. 2024 Apr 13:S0264-410X(24)00423-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults
18-49 years of age: Results of a randomized phase 3 study.
Vaccine. 2024 Apr 13:S0264-410X(24)00387-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection,
symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine
and to provide effective evaluation of the problem through social-medical and
behavioral-economic perspectives.
Vaccine. 2024 Apr 13:S0264-410X(24)00407-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native
children aged 9-14 years at 5 years after vaccination.
Vaccine. 2024 Apr 15:S0264-410X(24)00447-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Immunogenicity of Novel vB_EcoS_NBD2 Bacteriophage-Originated Nanotubes as a
Carrier for Peptide-Based Vaccines.
Virus Res. 2024 Apr 11:199370. doi: 10.1016/j.virusres.2024.199370.
PubMed
Abstract available
Thank you for your interest in scientific medicine.